29-Sep-16 Chinese companies have announced more than USD5.2 bn of overseas healthcare acquisitions in 2016, a 15-fold jump from 2012. "Even though China’s pharmaceutical industry is still in the middle of consolidation and price wars, we hope to escape from this and do more work in terms of innovation and internationalization," said Shao Yan, CEO of China Grand Pharma. [image: China Grand Pharmaceutical and Healthcare Holdings Ltd]

28-Sep-16 With the active ingredients in Traditional Chinese Medicine (TCM) now far better understood than ever before, a new range of hybrid TCM/Western treatments are wooing even the most cynical with their efficacy and lack of side-effects. Advances in research and development have enabled companies to integrate many of TCM's treatments and protocols with the latest technology and medical understanding. [image: HKTDC Research]

23-Sep-16 Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism. The zone in Boao is likely to attract patients who would otherwise travel to Hong Kong or Macau for drugs yet to be approved in China. [image: Anthony Wallace / AFP / Getty Images]

19-Sep-16 With China's demographic shifting towards an ever-higher ratio of citizens aged 60-plus, elder-friendly wearables are seen as a key means of monitoring the health and whereabouts of this affluent, yet vulnerable, sector of contemporary society. In the elderly sector, wearables tend to be either tracking devices or fall alarms. [image: HKTDC Research]

11-Sep-16 While demographers still assess the effects of the relaxation of the one-child policy, pregnant women and hospitals are feeling the squeeze. China forecasts that an extra 17 mn babies will be born within the next five years. In some of those years, there are expected to be more than 20 mn births. [image: South China Morning Post]